RE:RE:RE:RE:Jobs at LABSLemoyne wrote: Ahah, I didn't intend this message to hit you so hard, honestly. I'm an analyst, so I do have trouble with everything misinformation/ lack of critical reflection, especially in this day and age. It's not personal, I would've commented the same for anyone posting this kind of information.
As for my love affair with Keith, I would answer this: Is your opinion of Keiths uselessness impacting the way you interpret information/ bias? For me, that's a reasonable explanation of the post you made this morning.
How you decide to hit or how hard it totally up to you and certainly it doesn't bother me one way or the other what you believe my competency level to be.
One might assume that an aspect (perhaps large) of Strachan's role was local medical so it is not unreasonable that this new role is going to inherit a portion of his portfolio AND at a much lower salary than he was making, so while I wasn't as clear as I ought to have been, nothing in my post is 'misinformation' is simply a statement of opinion. Posting for a sales role (local or otherwise) shortly after shuffling out the 'sales and marketing' President has some optics associated with it.
And make no mistake, I personally didn't/don't find Strachan 'useless' but as an investor, as the sales and marketing guy C-suite guy, he has a hand in the SP being at an all-time low level so I'm not willing to give him a pass on that until the international/national partners/channels etc do some meaningful business. More than willing to claim mea culpa if Q3 hits big or we're taken out for north of a loonie however. lol